EMT may potentially help in immune evasion by boosting the expression of immunological checkpoint proteins on tumor cells, such as programmed-cell death ligand 1/2 (PD-L1/2) and B7-H3 [71–74]. The gene discussed is CD274; the disease is neoplasm.